查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790229

液体栓塞剂市场规模、份额和趋势分析报告：按产品类型、应用、最终用途、地区和细分市场预测，2025 年至 2033 年

Liquid Embolic Agent Market Size, Share & Trends Analysis Report By Product Type, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10个工作天内

价格

液体栓塞剂市场概况

2024 年全球液体栓塞剂市场规模估计为 2.579 亿美元，预计到 2033 年将达到 5.95 亿美元，2025 年至 2033 年的复合年增长率为 9.89%。液体栓塞剂产业的主要驱动力是微创手术的进步和全球血管疾病盛行率的不断上升。

随着医疗保健系统转向微创技术，用于治疗动脉瘤、动静脉畸形 (AVM) 和肿瘤等疾病的栓塞剂需求正在激增。神经血管和周边血管异常及疾病（尤其是动静脉畸形、硬脑膜动静脉瘘 (DAVF) 和富血管肿瘤）的增多是市场成长的主要驱动力。根据美国国家生物技术资讯中心发布的一项调查，约 15% 的动静脉畸形 (AVM) 病例在发生临床事件之前通常无症状。 41% 至 79% 的 AVM 与颅内出血有关。 AVM 是继脑动脉瘤之后第二常见的颅内出血原因，约占蜘蛛网膜下腔出血的 10%。

儿童比成人更容易出血。典型的出血部位是脑内，但也可能发生在蜘蛛网膜下腔。根据Radiopaedia.org 2024年11月的报告，孤立性动静脉畸形（AVM）的发生率为98%，多发性动静脉畸形（AVM）的发生率为2%。因此，AVM病例的增加是推动市场成长的主要因素。

此外，根据美国化学学会2021年4月发布的报告，脑动脉瘤是主要发生在脑血管分支的异常增大。目前，超过60%的动脉瘤采用微创血管内技术治疗，例如分流手术和永久性植入金属囊内弹簧圈。然而，这些现有设备在约20-30%的病例中初始成功率较低，且其整体有效性因动脉瘤的类型和位置而异。因此，这为预测期内液体栓塞剂产业带来了成长机会。

神经血管栓塞术通常使用液体栓塞Terumo Corporation进行，用于非生物分解乙烯 - 乙烯醇…这些栓塞剂因其能够有效闭塞异常血管，从而实现高精度和微创治疗而广受欢迎。栓塞剂的选择取决于具体的临床情况和病变特征，持续的技术创新旨在提高介入神经放射学手术的安全性、操作性和长期疗效。

目录

第一章调查方法与范围

第二章执行摘要

3. 液体栓塞剂市场变数、趋势和范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 液态栓塞剂市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析

第四章液体栓塞剂市场：依产品类型估计和趋势分析

  • 细分仪表板
  • 全球液体栓塞剂市场波动分析
  • 全球液体栓塞剂市场规模及趋势分析（依产品类型，2021-2033）
  • 乙烯 - 乙烯醇共聚物（EVOH）
  • 氰基丙烯酸酯
  • 其他的

第五章液体栓塞剂市场：应用估算与趋势分析

  • 细分仪表板
  • 全球液体栓塞剂市场波动分析
  • 全球液体栓塞剂市场规模及趋势分析（按应用，2021-2033）
  • 动静脉畸形（AVM）
  • 富血管肿瘤
  • 週边血管出血
  • 其他的

6. 液体栓塞剂市场：依最终用途的估计和趋势分析

  • 细分仪表板
  • 全球液体栓塞剂市场波动分析
  • 全球液体栓塞剂市场规模和趋势分析（按最终用途，2021-2033 年）
  • 医院
  • 专科诊所
  • 门诊手术中心（ASC）
  • 其他的

7. 液体栓塞剂市场：区域、估计和趋势分析（按产品类型、应用和最终用途）

  • 区域仪表板
  • 2021-2033 年市场规模、预测与趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • 2024 年主要企业全球市场占有率分析
    • Johnson & Johnson
    • Medtronic
    • B. Braun SE
    • Terumo
    • Boston Scientific Corporation
    • Balt
    • BlackSwan Vascular, Inc.
    • INVAMED
    • Meril
    • Gem srl
  • 热图分析/企业市场分析
  • 2024年企业市场占有率预测分析
  • 其他主要市场参与企业名单
Product Code: GVR-4-68040-692-5

Liquid Embolic Agent Market Summary

The global liquid embolic agent market size was estimated at USD 257.9 million in 2024 and is projected to reach USD 595.0 million by 2033, growing at a CAGR of 9.89% from 2025 to 2033. The liquid embolic agent industry is primarily driven by advancements in minimally invasive procedures and the increasing prevalence of vascular diseases worldwide.

As healthcare systems shift towards less invasive techniques, the demand for embolization agents used in treating conditions like aneurysms, arteriovenous malformations (AVMs), and tumors has surged. The growing neurovascular and peripheral vascular abnormalities and diseases such as AVMs, dural arteriovenous fistulas (DAVFs), and hypervascular tumors, among others are primarily driving the market growth. According to a research article published by the National Center for Biotechnology Information, arteriovenous malformations (AVMs) are often asymptomatic in about 15% of cases until a clinical event occurs. Between 41% and 79% of AVMs are present with intracranial hemorrhage. They are the second most common cause of intracranial bleeding after cerebral aneurysms, accounting for approximately 10% of all subarachnoid hemorrhages.

Children are more likely than adults to be present with hemorrhage. While hemorrhages are typically intraparenchymal, they can also primarily occur in the subarachnoid space. In addition, according to an article published by Radiopaedia.org in November 2024, the incidence of solitary AVM is 98% and multiple AVM is 2%. Thus, growing AVM cases are a primary contributor to market growth.

Furthermore, according to an American Chemical Society report published in April 2021, brain aneurysms are abnormal dilations that primarily develop at the branch points of cerebral blood vessels. Over 60% of aneurysms are now managed using minimally invasive endovascular techniques, such as flow diversion or the permanent placement of metallic intrasaccular coils. However, these current devices have an unfavorable primary success rate in approximately 20-30% of cases, and the overall effectiveness varies significantly depending on the aneurysm's type and location. Hence, this brings a growth opportunity for the liquid embolic agent industry during the forecast period.

Neurovascular embolization is commonly performed using liquid embolic agents to treat conditions such as AVMs, DAVFs, and hypervascular tumors. Currently, commonly used liquid embolic agents include n-butyl cyanoacrylate (n-BCA) and ethylene vinyl alcohol copolymer (EVOH) based agents, such as Onyx (Medtronic), Squid (Balt), and PHIL (Terumo), a non-biodegradable iodine-based liquid embolic agent. Additionally, TRUFILL (CERENOVUS, Johnson & Johnson) has recently been introduced. For instance, in March 2024, CERENOVUS, a division of Johnson & Johnson MedTech, announced the launch of the TRUFILL n-BCA Liquid Embolic System Procedural Set. This new offer expands CERENOVUS's hemorrhagic stroke portfolio by providing a comprehensive procedural set that includes two configuration options and all necessary accessories for preparing and delivering the TRUFILL n-BCA Liquid Embolic System. These agents are favored for their ability to effectively occlude abnormal vascular structures, providing minimally invasive treatment options with high precision. The choice of embolic agent depends on the specific clinical scenario and lesion characteristics, with ongoing innovations aiming to improve safety, handling, and long-term efficacy in neurointerventional procedures.

Global Liquid Embolic Agent Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global liquid embolic agent market report based on product type, application, end use, and region:

  • Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Ethylene Vinyl Alcohol Copolymer (EVOH)
  • Cyanoacrylates
    • N-BCA (n-Butyl Cyanoacrylate)
    • N-HCA (n-Hexyl Cyanoacrylate)
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Arteriovenous Malformations (AVM)
  • Hypervascular Tumors
  • Peripheral Vasculature Hemorrhage
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product Type
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Liquid Embolic Agent Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Prevalence of Vascular Diseases
      • 3.2.1.2. Advancements in Embolization Technologies
      • 3.2.1.3. Growing Preference for Minimally Invasive Procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of agents and materials
      • 3.2.2.2. Risk of complications and adverse events
      • 3.2.2.3. Availability of alternative treatments
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Technological innovations
      • 3.2.3.2. Growing number of clinical trials
      • 3.2.3.3. Expanding application areas
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Regulatory and approval barriers
  • 3.3. Liquid Embolic Agent Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Liquid Embolic Agent Market: Product Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Liquid Embolic Agent Market Movement Analysis
  • 4.3. Global Liquid Embolic Agent Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
  • 4.4. Ethylene Vinyl Alcohol Copolymer (EVOH)
    • 4.4.1. Ethylene Vinyl Alcohol Copolymer (EVOH) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Cyanoacrylates
    • 4.5.1. Cyanoacrylates Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.1. N-BCA (n-Butyl Cyanoacrylate)
        • 4.5.1.1.1. N-BCA (n-Butyl Cyanoacrylate) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.2. N-HCA (n-Hexyl Cyanoacrylate)
        • 4.5.1.2.1. N-HCA (n-Hexyl Cyanoacrylate) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Liquid Embolic Agent Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Liquid Embolic Agent Market Movement Analysis
  • 5.3. Global Liquid Embolic Agent Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Arteriovenous Malformations (AVM)
    • 5.4.1. Arteriovenous Malformations (AVM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Hypervascular Tumors
    • 5.5.1. Hypervascular Tumors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Peripheral Vasculature Hemorrhage
    • 5.6.1. Peripheral Vasculature Hemorrhage Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Liquid Embolic Agent Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Liquid Embolic Agent Market Movement Analysis
  • 6.3. Global Liquid Embolic Agent Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Specialty Clinics
    • 6.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Ambulatory Surgical Centers (ASCs)
    • 6.6.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Liquid Embolic Agent Market: Regional Estimates & Trend Analysis By Product Type, By Application, By End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. U.S. Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Canada Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Mexico Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. UK Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Germany Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. France Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Scenario
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Italy Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Scenario
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Spain Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Scenario
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Denmark Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Scenario
      • 7.4.8.4. Reimbursement Scenario
      • 7.4.8.5. Sweden Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Scenario
      • 7.4.9.4. Reimbursement Scenario
      • 7.4.9.5. Norway Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Japan Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. China Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. India Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Reimbursement Scenario
      • 7.5.5.5. South Korea Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Reimbursement Scenario
      • 7.5.6.5. Australia Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Reimbursement Scenario
      • 7.5.7.5. Thailand Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Brazil Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Argentina Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. South Africa Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Saudi Arabia Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Scenario
      • 7.7.4.4. Reimbursement Scenario
      • 7.7.4.5. UAE Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Scenario
      • 7.7.5.4. Reimbursement Scenario
      • 7.7.5.5. Kuwait Liquid Embolic Agent Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Global Key company market share analysis, 2024
    • 8.3.4. Johnson & Johnson
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Medtronic
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. B. Braun SE
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Terumo
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Boston Scientific Corporation
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Balt
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. BlackSwan Vascular, Inc.
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. INVAMED
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Product Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Meril
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Product Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. Gem srl
      • 8.3.13.1. Company Overview
      • 8.3.13.2. Financial Performance
      • 8.3.13.3. Product Benchmarking
      • 8.3.13.4. Strategic Initiatives
  • 8.4. Heat Map Analysis/ Company Market Position Analysis
  • 8.5. Estimated Company Market Share Analysis, 2024
  • 8.6. List of Other Key Market Players

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Liquid Embolic Agent Market, by Region, 2021 - 2033 (USD Million)
  • Table 4. Global Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 5. Global Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 6. Global Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 7. North America Liquid Embolic Agent Market, by Country, 2021 - 2033 (USD Million)
  • Table 8. North America Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 9. North America Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 10. North America Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 11. U.S. Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 12. U.S. Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 13. U.S. Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 14. Canada Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 15. Canada Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 16. Canada Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 17. Europe Liquid Embolic Agent Market, by Country, 2021 - 2033 (USD Million)
  • Table 18. Europe Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 19. Europe Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 20. Europe Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 21. Germany Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 22. Germany Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 23. Germany Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 24. UK Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 25. UK Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 26. UK Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 27. France Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 28. France Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 29. France Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 30. Italy Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 31. Italy Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 32. Italy Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 33. Spain Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 34. Spain Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 35. Spain Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 36. Denmark Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 37. Denmark Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 38. Denmark Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 39. Sweden Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 40. Sweden Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 41. Sweden Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 42. Norway Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 43. Norway Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 44. Norway Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 45. Asia Pacific Liquid Embolic Agent Market, by Country, 2021 - 2033 (USD Million)
  • Table 46. Asia Pacific Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 47. Asia Pacific Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 49. China Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 50. China Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 51. China Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 52. Japan Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 53. Japan Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 54. Japan Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 55. India Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 56. India Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 57. India Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 58. South Korea Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 59. South Korea Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 60. South Korea Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61. Australia Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 62. Australia Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 63. Australia Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 64. Thailand Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 65. Thailand Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 66. Thailand Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 67. Latin America Liquid Embolic Agent Market, by Country, 2021 - 2033 (USD Million)
  • Table 68. Latin America Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 69. Latin America Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 70. Latin America Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 71. Brazil Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 72. Brazil Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 73. Brazil Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 74. Mexico Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 75. Mexico Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 76. Mexico Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 77. Argentina Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 78. Argentina Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 79. Argentina Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa Liquid Embolic Agent Market, by Country, 2021 - 2033 (USD Million)
  • Table 81. Middle East & Africa Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 82. Middle East & Africa Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 83. Middle East & Africa Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 84. South Africa Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 85. South Africa Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 86. South Africa Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 89. Saudi Arabia Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 90. UAE Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 91. UAE Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 92. UAE Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 93. Kuwait Liquid Embolic Agent Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 94. Kuwait Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
  • Table 95. Kuwait Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
  • Table 96. Participant's Overview
  • Table 97. Financial Performance
  • Table 98. Product Benchmarking
  • Table 99. Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Liquid Embolic Agent Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Liquid Embolic Agent Market, for Ethylene Vinyl Alcohol Copolymer (EVOH), 2021 - 2033 (USD Million)
  • Fig. 15 Global Liquid Embolic Agent Market, for Cyanoacrylates, 2021 - 2033 (USD Million)
  • Fig. 16 Global Liquid Embolic Agent Market, for N-BCA (n-Butyl Cyanoacrylate), 2021 - 2033 (USD Million)
  • Fig. 17 Global Liquid Embolic Agent Market, for N-HCA (n-Hexyl Cyanoacrylate), 2021 - 2033 (USD Million)
  • Fig. 18 Global Liquid Embolic Agent Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 19 Global Liquid Embolic Agent Market, for Arteriovenous Malformations (AVM), 2021 - 2033 (USD Million)
  • Fig. 20 Global Liquid Embolic Agent Market, for Hypervascular Tumors, 2021 - 2033 (USD Million)
  • Fig. 21 Global Liquid Embolic Agent Market, for Peripheral Vasculature Hemorrhage, 2021 - 2033 (USD Million)
  • Fig. 22 Global Liquid Embolic Agent Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 23 Global Liquid Embolic Agent Market, for Hospitals, 2021 - 2033 (USD Million)
  • Fig. 24 Global Liquid Embolic Agent Market, for Specialty Clinics, 2021 - 2033 (USD Million)
  • Fig. 25 Global Liquid Embolic Agent Market, for Ambulatory Surgical Centers (ASCs), 2021 - 2033 (USD Million)
  • Fig. 26 Global Liquid Embolic Agent Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 27 Regional Outlook, 2024 & 2033
  • Fig. 28 North America Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 30 Canada Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 31 Europe Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 32 Germany Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 33 UK Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 34 France Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 35 Italy Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 36 Spain Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 37 Denmark Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 38 Sweden Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 39 Norway Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 40 Asia Pacific Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 41 Japan Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 42 China Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 43 India Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 44 Australia Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 45 South Korea Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 46 Thailand Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 47 Latin America Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 48 Brazil Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 49 Mexico Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 50 Argentina Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 51 Middle East and Africa Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 52 South Africa Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 53 Saudi Arabia Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 54 UAE Liquid Embolic Agent Market, 2021 - 2033 (USD Million)
  • Fig. 55 Kuwait Liquid Embolic Agent Market, 2021 - 2033 (USD Million)